506 related articles for article (PubMed ID: 28202050)
21. Identification and Expression Analysis of CD73 Inhibitors in Cervical Cancer.
Iqbal J; Basharat A; Bano S; Abid SMA; Pelletier J; Sévigny J
Med Chem; 2021; 17(8):866-874. PubMed ID: 32981507
[TBL] [Abstract][Full Text] [Related]
22. B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis.
Li Y; Zhang J; Han S; Qian Q; Chen Q; Liu L; Zhang Y
Oncol Rep; 2017 Aug; 38(2):1043-1050. PubMed ID: 28627681
[TBL] [Abstract][Full Text] [Related]
23. CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer.
Zhu J; Zeng Y; Li W; Qin H; Lei Z; Shen D; Gu D; Huang JA; Liu Z
Mol Cancer; 2017 Feb; 16(1):34. PubMed ID: 28158983
[TBL] [Abstract][Full Text] [Related]
24. The distinct role of CD73 in the progression of pancreatic cancer.
Zhou L; Jia S; Chen Y; Wang W; Wu Z; Yu W; Zhang M; Ding G; Cao L
J Mol Med (Berl); 2019 Jun; 97(6):803-815. PubMed ID: 30927045
[TBL] [Abstract][Full Text] [Related]
25. Adenosine inhibits migration, invasion and induces apoptosis of human cervical cancer cells.
Gao ZW; Wang HP; Dong K; Lin F; Wang X; Zhang HZ
Neoplasma; 2016; 63(2):201-7. PubMed ID: 26774140
[TBL] [Abstract][Full Text] [Related]
26. Role of CD73 in Disease: Promising Prognostic Indicator and Therapeutic Target.
Yang J; Liao X; Yu J; Zhou P
Curr Med Chem; 2018; 25(19):2260-2271. PubMed ID: 29345574
[TBL] [Abstract][Full Text] [Related]
27. MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma.
Bonnin N; Armandy E; Carras J; Ferrandon S; Battiston-Montagne P; Aubry M; Guihard S; Meyronet D; Foy JP; Saintigny P; Ledrappier S; Jung A; Rimokh R; Rodriguez-Lafrasse C; Poncet D
Oncotarget; 2016 Jul; 7(28):44023-44038. PubMed ID: 27281619
[TBL] [Abstract][Full Text] [Related]
28. Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody-Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function.
Jin R; Liu L; Xing Y; Meng T; Ma L; Pei J; Cong Y; Zhang X; Ren Z; Wang X; Shen J; Yu K
Mol Cancer Ther; 2020 Nov; 19(11):2340-2352. PubMed ID: 32943546
[TBL] [Abstract][Full Text] [Related]
29. Verteporfin Promotes the Apoptosis and Inhibits the Proliferation, Migration, and Invasion of Cervical Cancer Cells by Downregulating SULT2B1 Expression.
Yin L; Chen G
Med Sci Monit; 2020 Oct; 26():e926780. PubMed ID: 33079922
[TBL] [Abstract][Full Text] [Related]
30. Ecto-5'-nucleotidase (CD73) is a potential target of hepatocellular carcinoma.
Shali S; Yu J; Zhang X; Wang X; Jin Y; Su M; Liao X; Yu J; Zhi X; Zhou P
J Cell Physiol; 2019 Jul; 234(7):10248-10259. PubMed ID: 30417547
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancer cells produce TGF-β1 through the CD73-adenosine pathway and maintain CD73 expression through the autocrine activity of TGF-β1.
García-Rocha R; Monroy-García A; Hernández-Montes J; Weiss-Steider B; Gutiérrez-Serrano V; Del Carmen Fuentes-Castañeda M; Ávila-Ibarra LR; Don-López CA; Torres-Pineda DB; de Lourdes Mora-García M
Cytokine; 2019 Jun; 118():71-79. PubMed ID: 30301599
[TBL] [Abstract][Full Text] [Related]
32. Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors.
Sharif EU; Kalisiak J; Lawson KV; Miles DH; Newcomb E; Lindsey EA; Rosen BR; Debien LPP; Chen A; Zhao X; Young SW; Walker NP; Sträter N; Scaletti ER; Jin L; Xu G; Leleti MR; Powers JP
J Med Chem; 2021 Jan; 64(1):845-860. PubMed ID: 33399453
[TBL] [Abstract][Full Text] [Related]
33. Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo.
Salehi Khesht AM; Karpisheh V; Sahami Gilan P; Melnikova LA; Olegovna Zekiy A; Mohammadi M; Hojjat-Farsangi M; Majidi Zolbanin N; Mahmoodpoor A; Hassannia H; Aghebati-Maleki L; Jafari R; Jadidi-Niaragh F
Int J Biol Macromol; 2021 Sep; 186():849-863. PubMed ID: 34245737
[TBL] [Abstract][Full Text] [Related]
34. [FABP5 promotes cell growth, invasion and metastasis in cervical cancer].
Zhan YZ; Liu F; Zhang Y; Mo XY; Cheng WD; Wang W
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):200-207. PubMed ID: 30917456
[No Abstract] [Full Text] [Related]
35. CD73-TNAP crosstalk regulates the hypertrophic response and cardiomyocyte calcification due to α1 adrenoceptor activation.
Gan XT; Taniai S; Zhao G; Huang CX; Velenosi TJ; Xue J; Urquhart BL; Karmazyn M
Mol Cell Biochem; 2014 Sep; 394(1-2):237-46. PubMed ID: 24894822
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.
Cheng Y; Guo Y; Zhang Y; You K; Li Z; Geng L
J Exp Clin Cancer Res; 2016 Jan; 35():11. PubMed ID: 26769181
[TBL] [Abstract][Full Text] [Related]
37. Ecto-5'-nucleotidase, CD73, is an endothelium-derived hyperpolarizing factor synthase.
Ohta M; Toyama K; Gutterman DD; Campbell WB; Lemaître V; Teraoka R; Miura H
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):629-36. PubMed ID: 23288168
[TBL] [Abstract][Full Text] [Related]
38. CD73 is associated with poor prognosis in HNSCC.
Ren ZH; Lin CZ; Cao W; Yang R; Lu W; Liu ZQ; Chen YM; Yang X; Tian Z; Wang LZ; Li J; Wang X; Chen WT; Ji T; Zhang CP
Oncotarget; 2016 Sep; 7(38):61690-61702. PubMed ID: 27557512
[TBL] [Abstract][Full Text] [Related]
39. Alternative splicing of human NT5E in cirrhosis and hepatocellular carcinoma produces a negative regulator of ecto-5'-nucleotidase (CD73).
Snider NT; Altshuler PJ; Wan S; Welling TH; Cavalcoli J; Omary MB
Mol Biol Cell; 2014 Dec; 25(25):4024-33. PubMed ID: 25298403
[TBL] [Abstract][Full Text] [Related]
40. CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer.
Petruk N; Tuominen S; Åkerfelt M; Mattsson J; Sandholm J; Nees M; Yegutkin GG; Jukkola A; Tuomela J; Selander KS
Sci Rep; 2021 Mar; 11(1):6035. PubMed ID: 33727591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]